FCG Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,267
Closed -$330K 84
2024
Q4
$330K Buy
1,267
+154
+14% +$45.7K 0.2% 75
2024
Q3
$359K Sell
1,113
-2,401
-68% -$785K 0.24% 79
2024
Q2
$1.1M Buy
3,514
+167
+5% +$49.1K 0.83% 36
2024
Q1
$952K Buy
3,347
+1,176
+54% +$344K 0.76% 45
2023
Q4
$625K Buy
+2,171
New +$592K 0.61% 48

Other funds holding AMGN

FCG Investment Company's AMGN Position: Q1 2025 in Review

FCG Investment Company sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,267 shares — an estimated $330K sold.

FCG Investment Company first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.1M in Q2 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • FCG Investment Company reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • FCG Investment Company sold 1,267 Amgen shares in Q1 2025, an estimated $330K.
  • FCG Investment Company first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
  • FCG Investment Company's Amgen position peaked at $1.1M in Q2 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on FCG Investment Company's 13F filing for Q1 2025, filed 13 May 2025.